You refuse to compromise.
We couldn't agree more.
You refuse to compromise.
We couldn't agree more.
Latest product updates
Welcome to the Higher Standard.
Explore how Edwards SAPIEN 3 TAVI is designed to meet your Higher Standard.
With so much at stake, there's no room to compromise.
Edwards SAPIEN 3 TAVI helps you:
Delivering the outcomes you demand
1%
death or disabling
stroke 1 year
in low risk patients1,2
Perfect the pathway through efficient procedures
96%
of patients discharged to the
comfort of their own home1
Control for the future to continue to meet the emerging needs of new patient populations
100%
successful post-TAVI
coronary access
(68/68 patients)3
Stay informed with our newsletter
Thank you!
Thank you for signing up to the heartvalves.com newsletter. You will now receive emails on the latest developments and industry insights on heart valve innovation and technology.
References:
1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low Risk Patients. N Engl J Med. 2019;380:1695-1705.
2. Leon MB, Mack MJ. PARTNER 3: Transcatheter or Surgical Aortic-Valve Replacement in Low Risk Patients with Aortic Stenosis. Presented at: ACC 2019; New Orleans, LA.
3. Tarantini G, Fovino LN, Le Prince P, et al. Coronary access and percutaneous coronary intervention up to 3 years after transcatheter aortic implantation with a balloon-expandable valve. Circ Cardiovasc Interv. 2020;13(7):e008972.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
PP--EU-3363 v1.0